Stern Judy E, Gopal Daksha, Diop Hafsatou, Missmer Stacey A, Coddington Charles C, Luke Barbara
Department of Obstetrics & Gynecology and Pathology, Dartmouth-Hitchcock, Lebanon, NH, 03756, USA.
Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA.
J Assist Reprod Genet. 2017 Aug;34(8):1043-1049. doi: 10.1007/s10815-017-0961-z. Epub 2017 Jun 1.
The aim of this study is to evaluate frequency of hospitalization before, during, and after assisted reproductive technology (ART) treatment by cycle outcome.
Six thousand and one hundred thirty women residing in Massachusetts undergoing 17,135 cycles of ART reported to the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SARTCORS) from 2004 to 2011 were linked to hospital discharges and vital records. Women were grouped according to ART treatment cycle outcome as: no pregnancy (n = 1840), one or more pregnancies but no live birth (n = 968), or one or more singleton live births (n = 3322). Hospital delivery discharges during 1998-2011 were categorized as occurring before, during, or after the ART treatment. The most prevalent ICD-9 codes for non-delivery hospital discharges were compared. Groups were compared using chi square test using SAS 9.3 software.
The proportion of any hospitalization was 57.0, 58.3, and 91.3% for women with no pregnancy, no live birth, and ART singleton live birth, respectively; the proportion of non-delivery hospitalizations was 30.4, 31.0, and 28.3%, respectively. The non-ART delivery proportion after ART treatment did not differ by group (33.4, 36.2, and 36.9%, respectively, p = 0.17). Most frequent non-delivery diagnoses (including fibroids, obesity, ectopic pregnancy, depression, and endometriosis) also did not differ by group. A secondary analysis limited to only women with no delivery discharges before the first ART cycle showed similar results.
All groups had live birth deliveries during the study period, suggesting an important contribution of non-ART treatment or treatment-independent conception to overall delivery and live births. Hospitalizations not associated with delivery suggested similarity in morbidity for all ART patients regardless of success with ART treatment.
本研究旨在按周期结局评估辅助生殖技术(ART)治疗前、治疗期间及治疗后的住院频率。
2004年至2011年向辅助生殖技术协会诊所结局报告系统(SARTCORS)报告的居住在马萨诸塞州的6130名接受17135个ART周期治疗的女性与医院出院记录和生命记录相关联。女性根据ART治疗周期结局分为:未妊娠(n = 1840)、一次或多次妊娠但未活产(n = 968)、或一次或多次单胎活产(n = 3322)。1998 - 2011年期间的医院分娩出院记录被分类为发生在ART治疗前、治疗期间或治疗后。比较了非分娩医院出院记录中最常见的国际疾病分类第九版(ICD - 9)编码。使用SAS 9.3软件通过卡方检验对各组进行比较。
未妊娠、未活产和ART单胎活产的女性中,任何住院的比例分别为57.0%、58.3%和91.3%;非分娩住院的比例分别为30.4%、31.0%和28.3%。ART治疗后的非ART分娩比例在各组间无差异(分别为33.4%、36.2%和36.9%,p = 0.17)。最常见的非分娩诊断(包括子宫肌瘤、肥胖、异位妊娠、抑郁症和子宫内膜异位症)在各组间也无差异。一项仅限于首次ART周期前无分娩出院记录的女性的二次分析显示了相似的结果。
在研究期间所有组均有活产分娩,这表明非ART治疗或与治疗无关的受孕对总体分娩和活产有重要贡献。与分娩无关的住院表明,所有ART患者无论ART治疗是否成功,其发病率相似。